CYP1A1, cigarette smoking, and colon and rectal cancer

American Journal of Epidemiology

Volumn 160, Issue 9, 2004, Pages 842-852

  Slattery, Martha L ^a   Samowtiz, W ^b   Ma, K ^a   Murtaugh, M ^a   Sweeney, C ^a   Levin, T R ^c   Neuhausen, S ^d  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arylamine N acetyltransferase; Colorectal neoplasms; Cytochrome P 450 CYP1A1; GSTM1 protein; Smoking; Tobacco

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; UNCLASSIFIED DRUG;

CANCER; DISEASE PREVALENCE; SMOKING;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; EVALUATION; EXON; FEMALE; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; OBSERVATION; PHENOTYPE; RECTUM CANCER; UNITED STATES;

3' UNTRANSLATED REGIONS; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CALIFORNIA; CASE-CONTROL STUDIES; COCARCINOGENESIS; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP1A1; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMORPHISM, GENETIC; RISK FACTORS; SERINE ENDOPEPTIDASES; SMOKING; UTAH; VARIATION (GENETICS);

EID: 7244250184     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh298     Document Type: Article

References (34)

1. Nebert DW, Nelson DR, Coon MJ, et al. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 1991;10:1-14.
2. Nebert DW. Role of genetics and drug metabolism in human cancer risk. Mutat Res 1991;247:267-81.
3. Tefre T, Ryberg D, Haugen A, et al. Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1991;1:20-5.
4. Sivaraman L, Leatham MP, Yee J, et al. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 1994;54: 3692-5.
5. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, et al. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev 1992;1:485-9.
6. Vineis P. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 2002;181-182:457-62.
7. Crofts F, Taioli E, Trachman J, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994;15: 2961-3.
8. Cosma G, Crofts F, Currie D, et al. Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiol Biomarkers Prev 1993;2:53-7.
9. Persson I, Johansson I, Ingelman-Sundberg M. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun 1997;231:227-30.
10. Landi MT, Bertazzi PA, Shields PG, et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 1994;4:242-6.
11. Ichiba M, Hagmar L, Rannug A, et al. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis 1994;15:1347-52.
12. Kiyohara C, Wakai K, Mikami H, et al. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. Int J Cancer 2003;107:139-44.
13. Ishibe N, Stampfer M, Hunter DJ, et al. A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 2000;9:855-6.
14. Inoue H, Kiyohara C, Marugame T, et al. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas. Cancer Res 2000;60:3749-52.
15. Song N, Tan W, Xing D, et al. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 2001;22:11-16.
16. Chao A, Thun MJ, Jacobs EJ, et al. Cigarette smoking and colorectal cancer mortality in the Cancer Prevention Study II. J Natl Cancer Inst 2000;92:1888-96.
17. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-31.
18. Slattery ML, Potter JD, Friedman GD, et al. Tobacco use and colon cancer. Int J Cancer 1997;70:259-64.
19. Slattery ML, Edwards S, Curtin K, et al. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol Biomarkers Prev 2003;12:882-9.
20. Slattery ML, Curtin K, Ma K, et al. GSTM-1 and NAT2 and genetic alterations in colon tumors. Cancer Causes Control 2002;13:527-34.
21. Slattery ML, Edwards S, Curtin K, et al. Physical activity and colorectal cancer. Am J Epidemiol 2003;158:214-24.
22. Slattery ML, Potter J, Caan B, et al. Energy balance and colon cancer - beyond physical activity. Cancer Res 1997;57:75-80.
23. Edwards S, Slattery ML, Mori M, et al. Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 1994;140:1020-8.
24. Zhong S, Howie AF, Ketterer B, et al. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991;12:1533-7.
25. Bell DA, Taylor JA, Butler MA, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993;14:1689-92.
26. Kampman E, Slattery ML, Bigler J, et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. Cancer Epidemiol Biomarkers Prev 1999;8:15-24.
27. Hayashi SI, Watanabe J, Nakachi K, et al. PCR detection of an AJG polymorphism within exon 7 of the CYP1A1 gene. (Electronic article). Nucleic Acids Res 1991;19:4797.
28. Rebbeck TR, Rosvold EA, Duggan DJ, et al. Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epidemiol Biomarkers Prev 1994;3:511-14.
29. Slattery ML, Potter JD, Friedman GD, et al. Tobacco use and colon cancer. Int J Cancer 1997;70:259-64.
30. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
31. Taioli E, Gaspari L, Benhamou S, et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 2003;32:60-3.
32. Cauchi S, Stucker I, Cenee S, et al. Structure and polymorphisms of human aryl hydrocarbon receptor repressor (AhRR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer. Pharmacogenetics 2003;13:339-47.
33. Ishibe N, Wiencke JK, Zuo ZF, et al. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. Cancer Epidemiol Biomarkers Prev 1997;6:1075-80.
34. Ishibe N, Stampfer M, Hunter DJ, et al. A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 2000;9:855-6.